サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1339231

ゲノミクスにおけるAI市場、シェア、規模、動向、産業分析レポート：提供製品別、技術別、機能別、用途別、エンドユーザー別、地域別、セグメント別予測、2023年～2032年

AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ゲノミクスにおけるAI市場、シェア、規模、動向、産業分析レポート：提供製品別、技術別、機能別、用途別、エンドユーザー別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年07月23日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、ゲノミクスにおけるAIの世界市場規模は2032年までに167億5,795万米ドルに達する見込みです。このレポートは現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ゲノムデータの作成に必要な多額の財政支援は、市場の成長を促進する上で重要な役割を果たしています。国立ヒトゲノム研究所（NHGRI）のような機関は、多様なゲノムデータサイエンスイニシアチブを支援するために、年間1億2,500万米ドル以上の多額の資金を割り当てることで、この成長に大きく貢献しています。このような財政的支援により、研究者や組織は膨大なゲノムデータセットを作成し、蓄積することができます。ゲノムデータの量が増えるにつれて、この膨大な情報を効果的に分析し、そこから洞察を導き出すために、機械学習やディープラーニング・アルゴリズムを含むAI技術の需要が高まっています。

STRIDESのようなイニシアチブを通じた民間・商業クラウドと国立衛生研究所（NIH）のような政府・公的機関との連携が、市場の成長を後押ししています。これらの共同イニシアチブは、ゲノムデータをホストするためのストレージとコンピューティングインフラをサポートします。これらのイニシアチブは、ゲノム研究で生成される大量のゲノムデータを扱うためのスケーラブルで安全なプラットフォームを提供します。さらに、これらの企業は、機密性の高いヒトゲノムデータを保護するために、堅牢なセキュリティとプライバシー対策を実施することを優先しています。

ゲノミクスにおけるAI市場レポートハイライト

ソフトウェア分野は、ゲノムデータの増加により、今後数年間でより速い成長が見込まれます。

機械学習セグメントは、データ量と複雑性の増加により、最大の収益シェアを占めました。

ゲノムシーケンス分野は、DNAシーケンス技術の進歩により、最大の収益シェアを占めると予測されます。

プレシジョン・メディシンは、個別化治療アプローチの増加により、大きな成長率が見込まれます。

医薬品・バイオテクノロジー企業は、創薬の加速により大幅な成長が見込まれます。

北米は、ヘルスケア促進のための政府イニシアチブの高まりにより、最大の収益シェアを占めると予測されます。一方、欧州は、プロジェクトに資金を提供することで政府からの後押しを受け、より大きな収益シェアが見込まれます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のゲノミクスにおけるAI市場の洞察

  • ゲノミクスにおけるAI-業界スナップショット
  • ゲノミクスにおけるAI市場力学
    • 促進要因と機会
      • 生物医学調査プロジェクトの急激な成長
      • 技術の進歩と計算能力
    • 抑制要因と課題
      • データの品質と可用性
  • PESTLE分析
  • ゲノミクス業界におけるAIの動向
  • COVID-19感染症の影響分析

第5章 世界のゲノミクスにおけるAI市場、提供内容別

  • 主な調査結果
  • イントロダクション
  • ソフトウェア
  • サービス

第6章 世界のゲノミクスにおけるAI市場、テクノロジー別

  • 主な調査結果
  • イントロダクション
  • 機械学習
  • その他の技術

第7章 世界のゲノミクスにおけるAI市場、機能別

  • 主な調査結果
  • イントロダクション
  • ゲノム配列決定
  • 遺伝子編集
  • 臨床ワークフロー
  • 予測遺伝子検査と予防医学

第8章 世界のゲノミクスにおけるAI市場、アプリケーション別

  • 主な調査結果
  • イントロダクション
  • 診断
  • 創薬と開発
  • 精密医療
  • 農業および動物の調査
  • その他の用途

第9章 世界のゲノミクスにおけるAI市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 製薬会社およびバイオテクノロジー企業
  • ヘルスケア提供者
  • 研究センター、学術機関、政府機関
  • その他のエンドユーザー

第10章 世界のゲノミクスにおけるAI市場、地域別

  • 主な調査結果
  • イントロダクション
    • ゲノミクスにおけるAI市場評価、地域別、2019～2032年
  • ゲノミクスにおけるAI市場-北米
    • 北米：ゲノミクスにおけるAI市場、提供物別、2019～2032年
    • 北米：ゲノミクスにおけるAI市場、アプリケーション別、2019-2032年
    • 北米：ゲノミクスにおけるAI市場、テクノロジー別、2019-2032年
    • 北米：ゲノミクスにおけるAI市場、機能別、2019～2032年
    • 北米：ゲノミクスにおけるAI市場、エンドユーザー別、2019～2032年
    • ゲノミクスにおけるAI市場-米国
    • ゲノミクスにおけるAI市場-カナダ
  • ゲノミクスにおけるAI市場-欧州
    • 欧州：ゲノミクスにおけるAI市場、提供物別、2019～2032年
    • 欧州：ゲノミクスにおけるAI市場、アプリケーション別、2019～2032年
    • 欧州：ゲノミクスにおけるAI市場、テクノロジー別、2019～2032年
    • 欧州：ゲノミクスにおけるAI市場、機能別、2019～2032年
    • 欧州：ゲノミクスにおけるAI市場、エンドユーザー別、2019～2032年
    • ゲノミクスにおけるAI市場-英国
    • ゲノミクスにおけるAI市場-フランス
    • ゲノミクスにおけるAI市場-ドイツ
    • ゲノミクスにおけるAI市場-イタリア
    • ゲノミクスにおけるAI市場-スペイン
    • ゲノミクスにおけるAI市場-オランダ
    • ゲノミクスにおけるAI市場-ロシア
  • ゲノミクスにおけるAI市場-アジア太平洋
    • アジア太平洋：ゲノミクスにおけるAI市場、提供物別、2019～2032年
    • アジア太平洋：ゲノミクスにおけるAI市場、アプリケーション別、2019～2032年
    • アジア太平洋：ゲノミクスにおけるAI市場、テクノロジー別、2019～2032年
    • アジア太平洋：ゲノミクスにおけるAI市場、機能別、2019～2032年
    • アジア太平洋：ゲノミクスにおけるAI市場、エンドユーザー別、2019～2032年
    • ゲノミクスにおけるAI市場-中国
    • ゲノミクスにおけるAI市場-インド
    • ゲノミクスにおけるAI市場-日本
    • ゲノミクスにおけるAI市場-マレーシア
    • ゲノミクスにおけるAI市場-インドネシア
    • ゲノミクスにおけるAI市場-韓国
  • ゲノミクスにおけるAI市場-中東およびアフリカ
    • 中東およびアフリカ：ゲノミクスにおけるAI市場、提供物別、2019～2032年
    • 中東およびアフリカ：ゲノミクスにおけるAI市場、アプリケーション別、2019～2032年
    • 中東およびアフリカ：ゲノミクスにおけるAI市場、テクノロジー別、2019～2032年
    • 中東およびアフリカ：ゲノミクスにおけるAI市場、機能別、2019～2032年
    • 中東とアフリカ：ゲノミクスにおけるAI市場、エンドユーザー別、2019～2032年
    • ゲノミクスにおけるAI市場-サウジアラビア
    • ゲノミクスにおけるAI市場-UAE
    • ゲノミクスにおけるAI市場-イスラエル
    • ゲノミクスにおけるAI市場-南アフリカ
  • ゲノミクスにおけるAI市場-ラテンアメリカ
    • ラテンアメリカ：ゲノミクスにおけるAI市場、提供物別、2019～2032年
    • ラテンアメリカ：ゲノミクスにおけるAI市場、アプリケーション別、2019～2032年
    • ラテンアメリカ：ゲノミクスにおけるAI市場、テクノロジー別、2019-2032年
    • ラテンアメリカ：ゲノミクスにおけるAI市場、機能別、2019～2032年
    • ラテンアメリカ：ゲノミクスにおけるAI市場、エンドユーザー別、2019～2032年
    • ゲノミクスにおけるAI市場-メキシコ
    • ゲノミクスにおけるAI市場-ブラジル
    • ゲノミクスにおけるAI市場-アルゼンチン

第11章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第12章 企業プロファイル

  • Google DeepMind
  • IBM Watson Health
  • BenevolentAI
  • Tempus
  • Freenome
  • Sophia Genetics
  • 23andMe
  • DNAnexus
  • Recursion Pharmaceuticals
  • Verge Genomics
  • PathAI
  • GNS Healthcare
  • Freenome
  • Fabric Genomics
  • Foundation Medicine
  • SOPHiA GENETICS
  • Nebula Genomics
  • CytoReason
  • Genoox
  • Genalice
  • Deep Genomics
  • Owkin
  • Genialis
  • Gencove
  • Helix
  • QIAGEN Bioinformatics
  • SOPHiA DDM
  • WuXi NextCODE
  • Genuity Science
  • Lifebit
  • Envisagenics
  • ZS Genetics
  • MedGenome
  • Cypher Genomics
  • PierianDx
  • Bluebee
  • Repositive
  • Precision for Medicine
  • Shivom
  • Bluegnome
図表

List of Tables

  • Table 1 Global AI in Genomics Market, by Offering, by Region, 2019-2032 (USD Million)
  • Table 2 Global AI in Genomics Market, by Technology, by Region, 2019-2032 (USD Million)
  • Table 3 Global AI in Genomics Market, by Functionality, by Region, 2019-2032 (USD Million)
  • Table 4 Global AI in Genomics Market, by End User, by Region, 2019-2032 (USD Million)
  • Table 5 Global AI in Genomics Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 6 North America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 7 North America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 8 North America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 9 North America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 10 North America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 11 U.S.: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 12 U.S.: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 13 U.S.: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 14 U.S.: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 15 U.S.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 16 Canada: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 17 Canada: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 18 Canada: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 19 Canada: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 20 Canada: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 21 Europe: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 22 Europe: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 23 Europe: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 24 Europe: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 25 Europe: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 26 Germany: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 27 Germany: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 28 Germany: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 29 Germany: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 30 Germany: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 31 France: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 32 France: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 33 France: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 34 France: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 35 France: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 36 UK: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 37 UK: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 38 UK: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 39 UK: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 40 UK: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 41 Italy: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 42 Italy: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 43 Italy: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 44 Italy: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 45 Italy: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 46 Netherlands: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 47 Netherlands: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 48 Netherlands: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 49 Netherlands: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 50 Netherlands: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 51 Spain: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 52 Spain: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 53 Spain: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 54 Spain: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 55 Spain: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 56 Russia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 57 Russia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 58 Russia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 59 Russia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 60 Russia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 61 Asia Pacific: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 62 Asia Pacific: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 63 Asia Pacific: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 64 Asia Pacific: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 65 Asia Pacific: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 66 China: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 67 China: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 68 China: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 69 China: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 70 China: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 71 Japan: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 72 Japan: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 73 Japan: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 74 Japan: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 75 Japan: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 76 India: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 77 India: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 78 India: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 79 India: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 80 India: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 81 Indonesia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 82 Indonesia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 83 Indonesia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 84 Indonesia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 85 Indonesia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 86 Malaysia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 87 Malaysia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 88 Malaysia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 89 Malaysia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 90 Malaysia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 91 South Korea: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 92 South Korea: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 93 South Korea: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 94 South Korea: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 95 South Korea: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 96 Latin America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 97 Latin America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 98 Latin America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 99 Latin America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 100 Latin America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 101 Brazil: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 102 Brazil: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 103 Brazil: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 104 Brazil: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 105 Brazil: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 106 Mexico: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 107 Mexico: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 108 Mexico: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 109 Mexico: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 110 Mexico: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 111 Argentina: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 112 Argentina: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 113 Argentina: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 114 Argentina: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 115 Argentina: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 116 Middle East & Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 117 Middle East & Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 118 Middle East & Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 119 Middle East & Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 120 Middle East & Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 121 UAE: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 122 UAE: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 123 UAE: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 124 UAE: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 125 UAE: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 126 Saudi Arabia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 127 Saudi Arabia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 128 Saudi Arabia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 129 Saudi Arabia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 130 Saudi Arabia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 131 South Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 132 South Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 133 South Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 134 South Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 135 South Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 136 Israel: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 137 Israel: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 138 Israel: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 139 Israel: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 140 Israel: AI in Genomics Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global AI in Genomics Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Offering
  • Figure 7. Global AI in Genomics Market, by Offering, 2021 & 2030 (USD Million)
  • Figure 8. Market by Technology
  • Figure 9. Global AI in Genomics Market, by Technology, 2021 & 2030 (USD Million)
  • Figure 10. Market by Functionality
  • Figure 11. Global AI in Genomics Market, by Functionality, 2021 & 2030 (USD Million)
  • Figure 12. Market by End User
  • Figure 13. Global AI in Genomics Market, by End User, 2021 & 2030 (USD Million)
  • Figure 14. Market by Application
  • Figure 15. Global AI in Genomics Market, by Application, 2021 & 2030 (USD Million)
目次
Product Code: PM3611

The global AI in genomics market size is expected to reach USD 16,757.95 million by 2032, according to a new study by Polaris Market Research. The report "AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The substantial financial support required to generate genomic data plays a crucial role in driving the market's growth. Institutions like the National Human Genome Research Institute (NHGRI) contribute significantly to this growth by allocating substantial funding, with an annual investment of over $125 million, to support diverse genomic data science initiatives. This financial backing enables researchers and organizations to generate and accumulate extensive genomic datasets. As the volume of genomic data increases, the demand for AI technologies, including machine learning and deep learning algorithms, rises to effectively analyze and derive insights from this vast amount of information.

The collaboration between private & commercial cloud and governmental & public entities, such as the National Institutes of Health (NIH) through initiatives like STRIDES, drives the market's growth. These collaborative initiatives support the storage and computing infrastructure to host genomic data. They provide scalable and secure platforms to handle the large volumes of genomic data generated in genomics research. Additionally, they prioritize implementing robust security and privacy measures to safeguard sensitive human genomic data.

AI in Genomics Market Report Highlights

Software segment is anticipated to witness faster growth in the coming years due to the rise in genomic data.

Machine Learning segment accounted for the largest revenue share owing to the increased volume and complexity of data.

Genome Sequencing segment is projected to experience the largest revenue share due to the advancements in DNA sequencing technologies.

Precision Medicine is expected to witness significant growth rate due to growing personalized treatment approaches.

Pharmaceuticals and Biotech Companies are expected to grow at a substantial rate due to accelerated drug discovery.

North America is projected to witness largest revenue share owing to the rise in government initiatives to promote healthcare. While Europe is expected to grow a larger revenue share owing to the encouragement from the governments by funding the projects.

The global players include: Google DeepMind, QIAGEN Bioinformatics, SOPHiA DDM, WuXi NextCODE, Genuity Science, Lifebit, Envisagenics, ZS Genetics, MedGenome, Cypher Genomics, PierianDx, Bluebee, Repositive, Precision for Medicine, Shivom & Bluegnome.

Polaris Market Research has segmented the AI in Genomics market report based on offering, technology, functionality, application, end user and region:

AI in Genomics, Offering Outlook (Revenue - USD Million, 2019 - 2032)

  • Software
  • Services

AI in Genomics, Technology Outlook (Revenue - USD Million, 2019 - 2032)

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Unsupervised Learning
  • Reinforcement Learning
  • Other Machine Learning Technologies
  • Other Technologies

AI in Genomics, Functionality Outlook (Revenue - USD Million, 2019 - 2032)

  • Genome Sequencing
  • Gene Editing
  • Clinical Workflows
  • Predictive Genetic Testing & Preventive Medicine

AI in Genomics, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Diagnostics
  • Drug Discovery & Development
  • Precision Medicine
  • Agriculture & Animal Research
  • Other Applications

AI in Genomics, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical and Biotech Companies
  • Healthcare Providers
  • Research Centres, Academic Institutes and Government Organization
  • Other End Users

AI in Genomics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI in Genomics Market Insights

  • 4.1. AI in Genomics - Industry Snapshot
  • 4.2. AI in Genomics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Exponential growth of biomedical research projects
      • 4.2.1.2. Technological advancements and computational power
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data quality and availability
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. AI in Genomics Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global AI in Genomics Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • 5.3. Software
    • 5.3.1. Global AI in Genomics Market, by Software, by Region, 2019-2032 (USD Million)
  • 5.4. Services
    • 5.4.1. Global AI in Genomics Market, by Services, by Region, 2019-2032 (USD Million)

6. Global AI in Genomics Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • 6.3. Machine Learning
    • 6.3.1. Global AI in Genomics Market, by Machine Learning, by Region, 2019-2032 (USD Million)
    • 6.3.2. Deep Learning
      • 6.3.2.1. Global AI in Genomics Market, by Deep Learning, by Region, 2019-2032 (USD Million)
    • 6.3.3. Supervised Learning
      • 6.3.3.1. Global AI in Genomics Market, by Supervised Learning, by Region, 2019-2032 (USD Million)
    • 6.3.4. Unsupervised Learning
      • 6.3.4.1. Global AI in Genomics Market, by Unsupervised Learning, by Region, 2019-2032 (USD Million)
    • 6.3.5. Reinforcement Learning
      • 6.3.5.1. Global AI in Genomics Market, by Reinforcement Learning, by Region, 2019-2032 (USD Million)
    • 6.3.6. Other Machine Learning Technologies
      • 6.3.6.1. Global AI in Genomics Market, by Other Machine Learning Technologies, by Region, 2019-2032 (USD Million)
  • 6.4. Others Technologies
    • 6.4.1. Global AI in Genomics Market, by Others Technologies, by Region, 2019-2032 (USD Million)

7. Global AI in Genomics Market, by Functionality

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • 7.3. Genome Sequencing
    • 7.3.1. Global AI in Genomics Market, by Genome Sequencing, by Region, 2019-2032 (USD Million)
  • 7.4. Gene Editing
    • 7.4.1. Global AI in Genomics Market, by Gene Editing, by Region, 2019-2032 (USD Million)
  • 7.5. Clinical Workflows
    • 7.5.1. Global AI in Genomics Market, by Clinical Workflows, by Region, 2019-2032 (USD Million)
  • 7.6. Predictive Genetic Testing & Preventive Medicine
    • 7.6.1. Global AI in Genomics Market, by Predictive Genetic Testing & Preventive Medicine, by Region, 2019-2032 (USD Million)

8. Global AI in Genomics Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • 8.3. Diagnostics
    • 8.3.1. Global AI in Genomics Market, by Diagnostics, by Region, 2019-2032 (USD Million)
  • 8.4. Drug Discovery & Development
    • 8.4.1. Global AI in Genomics Market, by Drug Discovery & Development, by Region, 2019-2032 (USD Million)
  • 8.5. Precision Medicine
    • 8.5.1. Global AI in Genomics Market, by Precision Medicine, by Region, 2019-2032 (USD Million)
  • 8.6. Agriculture & Animal Research
    • 8.6.1. Global AI in Genomics Market, by Agriculture & Animal Research, by Region, 2019-2032 (USD Million)
  • 8.7. Other Applications
    • 8.7.1. Global AI in Genomics Market, by Other Applications, by Region, 2019-2032 (USD Million)

9. Global AI in Genomics Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 9.3. Pharmaceutical and Biotech Companies
    • 9.3.1. Global AI in Genomics Market, by Pharmaceutical and Biotech Companies, by Region, 2019-2032 (USD Million)
  • 9.4. Healthcare Providers
    • 9.4.1. Global AI in Genomics Market, by Healthcare Providers, by Region, 2019-2032 (USD Million)
  • 9.5. Research Centres, Academic Institutes and Government Organization
    • 9.5.1. Global AI in Genomics Market, by Research Centres, Academic Institutes and Government Organization, by Region, 2019-2032 (USD Million)
  • 9.6. Other End Users
    • 9.6.1. Global AI in Genomics Market, by Other End Users, by Region, 2019-2032 (USD Million)

10. Global AI in Genomics Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. AI in Genomics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 10.3. AI in Genomics Market - North America
    • 10.3.1. North America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.3.2. North America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.3.3. North America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.3.4. North America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.3.5. North America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.3.6. AI in Genomics Market - U.S.
      • 10.3.6.1. U.S.: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.3.6.2. U.S.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.3.6.3. U.S.: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.3.6.4. U.S.: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.3.6.5. U.S.: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.3.7. AI in Genomics Market - Canada
      • 10.3.7.1. Canada: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.3.7.2. Canada.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.3.7.3. Canada: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.3.7.4. Canada: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.3.7.5. Canada: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.4. AI in Genomics Market - Europe
    • 10.4.1. Europe: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.4.2. Europe.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.4.3. Europe: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.4. Europe: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.4.5. Europe: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.6. AI in Genomics Market - UK
      • 10.4.6.1. UK: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.6.2. UK.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.6.3. UK: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.6.4. UK: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.6.5. UK: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.7. AI in Genomics Market - France
      • 10.4.7.1. France: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.7.2. France.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.7.3. France: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.7.4. France: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.7.5. France: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.8. AI in Genomics Market - Germany
      • 10.4.8.1. Germany: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.8.2. Germany.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.8.3. Germany: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.8.4. Germany: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.8.5. Germany: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.9. AI in Genomics Market - Italy
      • 10.4.9.1. Italy: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.9.2. Italy.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.9.3. Italy: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.9.4. Italy: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.9.5. Italy: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.10. AI in Genomics Market - Spain
      • 10.4.10.1. Spain: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.10.2. Spain.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.10.3. Spain: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.10.4. Spain: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.10.5. Spain: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.11. AI in Genomics Market - Netherlands
      • 10.4.11.1. Netherlands: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.11.2. Netherlands.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.11.3. Netherlands: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.11.4. Netherlands: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.11.5. Netherlands: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.12. AI in Genomics Market - Russia
      • 10.4.12.1. Russia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.12.2. Russia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.12.3. Russia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.12.4. Russia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.12.5. Russia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.5. AI in Genomics Market - Asia Pacific
    • 10.5.1. Asia Pacific: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.5.2. Asia Pacific.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.5.3. Asia Pacific: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.4. Asia Pacific: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.5.5. Asia Pacific: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.6. AI in Genomics Market - China
      • 10.5.6.1. China: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.6.2. China.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.6.3. China: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.6.4. China: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.6.5. China: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.7. AI in Genomics Market - India
      • 10.5.7.1. India: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.7.2. India.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.7.3. India: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.7.4. India: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.7.5. India: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.8. AI in Genomics Market - Japan
      • 10.5.8.1. Japan: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.8.2. Japan.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.8.3. Japan: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.8.4. Japan: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.8.5. Japan: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.9. AI in Genomics Market - Malaysia
      • 10.5.9.1. Malaysia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.9.2. Malaysia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.9.3. Malaysia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.9.4. Malaysia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.9.5. Malaysia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.10. AI in Genomics Market - Indonesia
      • 10.5.10.1. Indonesia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.10.2. Indonesia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.10.3. Indonesia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.10.4. Indonesia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.10.5. Indonesia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.11. AI in Genomics Market - South Korea
      • 10.5.11.1. South Korea: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.11.2. South Korea.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.11.3. South Korea: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.11.4. South Korea: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.11.5. South Korea: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.6. AI in Genomics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.6.2. Middle East & Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.6.3. Middle East & Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.6.4. Middle East & Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.6.5. Middle East & Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.6. AI in Genomics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.6.2. Saudi Arabia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.6.3. Saudi Arabia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.6.4. Saudi Arabia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.6.5. Saudi Arabia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.7. AI in Genomics Market - UAE
      • 10.6.7.1. UAE: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.7.2. UAE.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.7.3. UAE: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.7.4. UAE: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.7.5. UAE: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.8. AI in Genomics Market - Israel
      • 10.6.8.1. Israel: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.8.2. Israel.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.8.3. Israel: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.8.4. Israel: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.8.5. Israel: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.9. AI in Genomics Market - South Africa
      • 10.6.9.1. South Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.9.2. South Africa.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.9.3. South Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.9.4. South Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.9.5. South Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.7. AI in Genomics Market - Latin America
    • 10.7.1. Latin America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.7.2. Latin America.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.7.3. Latin America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.7.4. Latin America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.7.5. Latin America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.7.6. AI in Genomics Market - Mexico
      • 10.7.6.1. Mexico: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.7.6.2. Mexico.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.7.6.3. Mexico: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.6.4. Mexico: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.7.6.5. Mexico: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.7.7. AI in Genomics Market - Brazil
      • 10.7.7.1. Brazil: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.7.7.2. Brazil.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.7.7.3. Brazil: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.7.4. Brazil: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.7.7.5. Brazil: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.7.8. AI in Genomics Market - Argentina
      • 10.7.8.1. Argentina: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.7.8.2. Argentina.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.7.8.3. Argentina: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.8.4. Argentina: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.7.8.5. Argentina: AI in Genomics Market, by End User, 2019-2032 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Google DeepMind
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. IBM Watson Health
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. BenevolentAI
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Tempus
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Freenome
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Sophia Genetics
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. 23andMe
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. DNAnexus
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Recursion Pharmaceuticals
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Verge Genomics
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. PathAI
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. GNS Healthcare
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Freenome
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development
  • 12.14. Fabric Genomics
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Benchmarking
    • 12.14.4. Recent Development
  • 12.15. Foundation Medicine
    • 12.15.1. Company Overview
    • 12.15.2. Financial Performance
    • 12.15.3. Product Benchmarking
    • 12.15.4. Recent Development
  • 12.16. SOPHiA GENETICS
    • 12.16.1. Company Overview
    • 12.16.2. Financial Performance
    • 12.16.3. Product Benchmarking
    • 12.16.4. Recent Development
  • 12.17. Nebula Genomics
    • 12.17.1. Company Overview
    • 12.17.2. Financial Performance
    • 12.17.3. Product Benchmarking
    • 12.17.4. Recent Development
  • 12.18. CytoReason
    • 12.18.1. Company Overview
    • 12.18.2. Financial Performance
    • 12.18.3. Product Benchmarking
    • 12.18.4. Recent Development
  • 12.19. Genoox
    • 12.19.1. Company Overview
    • 12.19.2. Financial Performance
    • 12.19.3. Product Benchmarking
    • 12.19.4. Recent Development
  • 12.20. Genalice
    • 12.20.1. Company Overview
    • 12.20.2. Financial Performance
    • 12.20.3. Product Benchmarking
    • 12.20.4. Recent Development
  • 12.21. Deep Genomics
    • 12.21.1. Company Overview
    • 12.21.2. Financial Performance
    • 12.21.3. Product Benchmarking
    • 12.21.4. Recent Development
  • 12.22. Owkin
    • 12.22.1. Company Overview
    • 12.22.2. Financial Performance
    • 12.22.3. Product Benchmarking
    • 12.22.4. Recent Development
  • 12.23. Genialis
    • 12.23.1. Company Overview
    • 12.23.2. Financial Performance
    • 12.23.3. Product Benchmarking
    • 12.23.4. Recent Development
  • 12.24. Gencove
    • 12.24.1. Company Overview
    • 12.24.2. Financial Performance
    • 12.24.3. Product Benchmarking
    • 12.24.4. Recent Development
  • 12.25. Helix
    • 12.25.1. Company Overview
    • 12.25.2. Financial Performance
    • 12.25.3. Product Benchmarking
    • 12.25.4. Recent Development
  • 12.26. QIAGEN Bioinformatics
    • 12.26.1. Company Overview
    • 12.26.2. Financial Performance
    • 12.26.3. Product Benchmarking
    • 12.26.4. Recent Development
  • 12.27. SOPHiA DDM
    • 12.27.1. Company Overview
    • 12.27.2. Financial Performance
    • 12.27.3. Product Benchmarking
    • 12.27.4. Recent Development
  • 12.28. WuXi NextCODE
    • 12.28.1. Company Overview
    • 12.28.2. Financial Performance
    • 12.28.3. Product Benchmarking
    • 12.28.4. Recent Development
  • 12.29. Genuity Science
    • 12.29.1. Company Overview
    • 12.29.2. Financial Performance
    • 12.29.3. Product Benchmarking
    • 12.29.4. Recent Development
  • 12.30. Lifebit
    • 12.30.1. Company Overview
    • 12.30.2. Financial Performance
    • 12.30.3. Product Benchmarking
    • 12.30.4. Recent Development
  • 12.31. Envisagenics
    • 12.31.1. Company Overview
    • 12.31.2. Financial Performance
    • 12.31.3. Product Benchmarking
    • 12.31.4. Recent Development
  • 12.32. ZS Genetics
    • 12.32.1. Company Overview
    • 12.32.2. Financial Performance
    • 12.32.3. Product Benchmarking
    • 12.32.4. Recent Development
  • 12.33. MedGenome
    • 12.33.1. Company Overview
    • 12.33.2. Financial Performance
    • 12.33.3. Product Benchmarking
    • 12.33.4. Recent Development
  • 12.34. Cypher Genomics
    • 12.34.1. Company Overview
    • 12.34.2. Financial Performance
    • 12.34.3. Product Benchmarking
    • 12.34.4. Recent Development
  • 12.35. PierianDx
    • 12.35.1. Company Overview
    • 12.35.2. Financial Performance
    • 12.35.3. Product Benchmarking
    • 12.35.4. Recent Development
  • 12.36. Bluebee
    • 12.36.1. Company Overview
    • 12.36.2. Financial Performance
    • 12.36.3. Product Benchmarking
    • 12.36.4. Recent Development
  • 12.37. Repositive
    • 12.37.1. Company Overview
    • 12.37.2. Financial Performance
    • 12.37.3. Product Benchmarking
    • 12.37.4. Recent Development
  • 12.38. Precision for Medicine
    • 12.38.1. Company Overview
    • 12.38.2. Financial Performance
    • 12.38.3. Product Benchmarking
    • 12.38.4. Recent Development
  • 12.39. Shivom
    • 12.39.1. Company Overview
    • 12.39.2. Financial Performance
    • 12.39.3. Product Benchmarking
    • 12.39.4. Recent Development
  • 12.40. Bluegnome
    • 12.40.1. Company Overview
    • 12.40.2. Financial Performance
    • 12.40.3. Product Benchmarking
    • 12.40.4. Recent Development